Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2017 Apr 1

PMID 28360914

Citations 152

Authors

Xenia Geeraerts

Evangelia Bolli

Sarah-Maria Fendt

Jo A Van Ginderachter

Affiliations

Soon will be listed here.

Abstract

Macrophages are not only essential components of innate immunity that contribute to host defense against infections, but also tumor growth and the maintenance of tissue homeostasis. An important feature of macrophages is their plasticity and ability to adopt diverse activation states in response to their microenvironment and in line with their functional requirements. Recent immunometabolism studies have shown that alterations in the metabolic profile of macrophages shape their activation state and function. For instance, to fulfill their respective functions lipopolysaccharides-induced pro-inflammatory macrophages and interleukin-4 activated anti-inflammatory macrophages adopt a different metabolism. Thus, metabolic reprogramming of macrophages could become a therapeutic approach to treat diseases that have a high macrophage involvement, such as cancer. In the first part of this review, we will focus on the metabolic pathways altered in differentially activated macrophages and link their metabolic aspects to their pro- and anti-inflammatory phenotype. In the second part, we will discuss how macrophage metabolism is a promising target for therapeutic intervention in inflammatory diseases and cancer.

Citing Articles

Linking macrophage metabolism to function in the tumor microenvironment.

Jin R, Neufeld L, McGaha T Nat Cancer. 2025; 6(2):239-252.

PMID: 39962208 DOI: 10.1038/s43018-025-00909-2.

The Yin-Yang functions of macrophages in metabolic disorders.

Bai J, Liu F Life Med. 2025; 1(3):319-332.

PMID: 39872753 PMC: 11749365. DOI: 10.1093/lifemedi/lnac035.

Hepatoma cell-derived exosomal SNORD52 mediates M2 macrophage polarization by activating the JAK2/STAT6 pathway.

Zhang Y, Li B, Gu W, Fan L, Wang X, Xu M Discov Oncol. 2025; 16(1):36.

PMID: 39804511 PMC: 11730036. DOI: 10.1007/s12672-024-01700-y.

Metabolic Signaling in the Tumor Microenvironment.

Clay R, Li K, Jin L Cancers (Basel). 2025; 17(1.

PMID: 39796781 PMC: 11719658. DOI: 10.3390/cancers17010155.

Metabolic Crossroad Between Macrophages and Cancer Cells: Overview of Hepatocellular Carcinoma.

Santarsiero A, Convertini P, Iacobazzi D, Infantino V, Todisco S Biomedicines. 2025; 12(12.

PMID: 39767591 PMC: 11727080. DOI: 10.3390/biomedicines12122684.

References

Galvan-Pena S, ONeill L . Metabolic reprograming in macrophage polarization. Front Immunol. 2014; 5:420. PMC: 4151090. DOI: 10.3389/fimmu.2014.00420. View

Tan Z, Xie N, Banerjee S, Cui H, Fu M, Thannickal V . The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages. J Biol Chem. 2014; 290(1):46-55. PMC: 4281748. DOI: 10.1074/jbc.M114.603589. View

Stoger J, Gijbels M, van der Velden S, Manca M, van der Loos C, Biessen E . Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis. 2012; 225(2):461-8. DOI: 10.1016/j.atherosclerosis.2012.09.013. View

Wenes M, Shang M, Di Matteo M, Goveia J, Martin-Perez R, Serneels J . Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis. Cell Metab. 2016; 24(5):701-715. DOI: 10.1016/j.cmet.2016.09.008. View

Zhang Q, Liu L, Gong C, Shi H, Zeng Y, Wang X . Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One. 2013; 7(12):e50946. PMC: 3532403. DOI: 10.1371/journal.pone.0050946. View

Rodriguez-Prados J, Traves P, Cuenca J, Rico D, Aragones J, Martin-Sanz P . Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol. 2010; 185(1):605-14. DOI: 10.4049/jimmunol.0901698. View

Pearce E, Poffenberger M, Chang C, Jones R . Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013; 342(6155):1242454. PMC: 4486656. DOI: 10.1126/science.1242454. View

Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent E, Loginicheva E . Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. Cell Metab. 2016; 24(1):158-66. PMC: 5108454. DOI: 10.1016/j.cmet.2016.06.004. View

Huang S, Everts B, Ivanova Y, OSullivan D, Nascimento M, Smith A . Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol. 2014; 15(9):846-55. PMC: 4139419. DOI: 10.1038/ni.2956. View

10.

Van Ginderachter J, Movahedi K, Hassanzadeh Ghassabeh G, Meerschaut S, Beschin A, Raes G . Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology. 2006; 211(6-8):487-501. DOI: 10.1016/j.imbio.2006.06.002. View

11.

Feig J, Parathath S, Rong J, Mick S, Vengrenyuk Y, Grauer L . Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation. 2011; 123(9):989-98. PMC: 3131163. DOI: 10.1161/CIRCULATIONAHA.110.984146. View

12.

Casazza A, Laoui D, Wenes M, Rizzolio S, Bassani N, Mambretti M . Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell. 2013; 24(6):695-709. DOI: 10.1016/j.ccr.2013.11.007. View

13.

Rath M, Muller I, Kropf P, Closs E, Munder M . Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Front Immunol. 2014; 5:532. PMC: 4209874. DOI: 10.3389/fimmu.2014.00532. View

14.

Mills E, Kelly B, Logan A, Costa A, Varma M, Bryant C . Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages. Cell. 2016; 167(2):457-470.e13. PMC: 5863951. DOI: 10.1016/j.cell.2016.08.064. View

15.

Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O . Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci U S A. 2013; 110(19):7820-5. PMC: 3651434. DOI: 10.1073/pnas.1218599110. View

16.

Phillip West A, Brodsky I, Rahner C, Woo D, Erdjument-Bromage H, Tempst P . TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011; 472(7344):476-80. PMC: 3460538. DOI: 10.1038/nature09973. View

17.

Pike L, Smift A, Croteau N, Ferrick D, Wu M . Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 2011; 1807(6):726-34. DOI: 10.1016/j.bbabio.2010.10.022. View

18.

Colegio O, Chu N, Szabo A, Chu T, Rhebergen A, Jairam V . Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014; 513(7519):559-63. PMC: 4301845. DOI: 10.1038/nature13490. View

19.

Chang C, Pearce E . Emerging concepts of T cell metabolism as a target of immunotherapy. Nat Immunol. 2016; 17(4):364-8. PMC: 4990080. DOI: 10.1038/ni.3415. View

20.

Engblom C, Pfirschke C, Pittet M . The role of myeloid cells in cancer therapies. Nat Rev Cancer. 2016; 16(7):447-62. DOI: 10.1038/nrc.2016.54. View